Pharmerica (PMC) Tops Q1 EPS by 5c

Pharmerica (NYSE: PMC) reported Q1 EPS of $0.48, $0.05 better than the analyst estimate of $0.43. Revenue for the quarter came in at $511.6 million versus the consensus estimate of $500.95 million.

Pharmerica sees FY2015 EPS of $1.55-$1.65, versus the consensus of $1.62. Pharmerica sees FY2015 revenue of $1.95-2.05 billion, versus the consensus of $2.03 billion.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• JPMorgan (JPM) Tops Q2 EPS by $2.15, Beats on Revenue
• Beam Global reports Q2 2026 revenue above $8.5M, up 170% from Q1